TNF and rheumatoid arthritis: According to the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis, if a patient treated with TNF inhibitor is a primary non-responder or develops secondary non-responsiveness over time, the treatment with this drug should be discontinuated.